After 10 years of positive and satisfactory activities, in agreement with the Foundation, the Board of Directors has deemed it necessary to change the operational structure of the Foundation with the goal of instilling a new vision focused on instigating and supporting investigative work and monitoring new clinical trials on order to be able to offer patients access to experimental treatments supported by solid preclinical research. This new cycle that we will undertake will mainly involve restructuring the entire Technical Scientific Committee into a leaner organization that will operate in continuous close contact with the Board of Directors.